Antibody therapies for melanoma: New and emerging opportunities to activate immunity (Review)

The interface between malignant melanoma and patient immunity has long been recognised and efforts to treat this most lethal form of skin cancer by activating immune responses with cytokine, vaccine and also antibody immunotherapies have demonstrated promise in limited subsets of patients. In the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: MALAS, SADEK, HARRASSER, MICAELA, LACY, KATIE E., KARAGIANNIS, SOPHIA N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121424/
https://www.ncbi.nlm.nih.gov/pubmed/24969320
http://dx.doi.org/10.3892/or.2014.3275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121424/
https://www.ncbi.nlm.nih.gov/pubmed/24969320
http://dx.doi.org/10.3892/or.2014.3275

Ejemplares similares